Gland Pharma IPO GMP Price

Gland Pharma IPO Date, GMP, Price Band and all you need to know

Gland Pharma Limited IPO (Gland Pharma IPO) Detail. Gland Pharma Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products.

To become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.

Gland Pharma operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables.

This presence across the value chain has helped us witness exponential growth.

Company promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Gland Pharma IPO Details

The company plans to raise Rs 6,480 crore through the maiden offer at a price band of Rs 1,490-1,500 apiece. The issue comprises a fresh issue of equity shares worth Rs 1,250 crore, and offer for sale for 3.5 crore shares by promoters and other shareholders.

IPO DateNov 9, 2020 to Nov 11, 2020
Issue TypeBook Built Issue IPO
Issue Size43,196,968 Eq Shares of ₹1
(aggregating up to ₹6,479.55 Cr)
Fresh Issue8,333,333 Eq Shares of ₹1
(aggregating up to ₹1,250.00 Cr)
Offer for Sale34,863,635 Eq Shares of ₹1
(aggregating up to ₹5,229.55 Cr)
Face Value₹1 per equity share
IPO Price₹1490 to ₹1500 per equity share
Market Lot10 Shares
Min Order Quantity10 Shares
Listing AtBSE, NSE

Gland Pharma Important Dates

Bid/Offer Opens OnNov 9, 2020
Bid/Offer Closes OnNov 11, 2020
Finalisation of Basis of AllotmentNov 17, 2020
Initiation of RefundsNov 18, 2020
Credit of Shares to Demat AcctNov 19, 2020
IPO Shares Listing DateNov 20, 2020

Gland Pharma IPO Lot Size and Min/Max Investment

ApplicationLotsSharesAmount (Cut-off)
Minimum110₹15,000
Maximum13130₹195,000

Gland Pharma’s Financials

ParameterFY18FY19FY20Jun 2020
Revenue1,6722,1302,772916
Profit321452773314
Borrowings6555
Net Worth2,4102,8623,6463,963
Source: Red Herring Prospectus, (₹ in crore)

Kotak Mahindra Capital Company Ltd., Citigroup Global Markets India Pvt., Haitong Securities India Pvt. and Nomura Financial Advisory and Securities (India) Pvt. are the lead managers to the issue.

The company has already allocated 1.30 crore equity shares at Rs 1,500 apiece to 70 anchor investors, raising Rs 1,944 crore ahead of the IPO.

Leave a Reply